Vyvanse 60 mg

VYVANSE 60 MG chewable tablets contain lisdexamfetamine dimesylate, a central nervous system stimulant. This medication is commonly used to manage ADHD symptoms in patients aged 6 and older. It is also prescribed for binge eating disorders in adults.

VYVANSE 60 MG chewable tablets are primarily used to treat attention deficit hyperactivity disorder (ADHD) in children and adults. The active ingredient, lisdexamfetamine dimesylate, helps improve focus and reduce impulsivity. Additionally, VYVANSE is prescribed for moderate to severe binge eating disorders in adults, helping to control episodes of compulsive eating.

Common effects of VYVANSE 60 MG may include increased alertness, improved concentration, and reduced appetite. Some users may experience mild side effects such as dry mouth, insomnia, or decreased appetite. These effects can vary depending on individual metabolism and other factors.

VYVANSE 60 MG should be stored at room temperature, away from moisture and heat. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be shared with others, even if they have similar symptoms.

VYVANSE 60 MG may interact with certain medications, including MAO inhibitors, antidepressants, and blood pressure medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while taking VYVANSE, as it may exacerbate side effects.